Clinical trial / 2012
Ingestion of 6 g Ceylon cinnamon did not significantly affect postprandial glucose, insulin response, GI, or GII in subjects with impaired glucose tolerance.
A crossover trial assessed 10 subjects with impaired glucose tolerance receiving a standard 75 g oral glucose tolerance test with either placebo or Cinnamomum zeylanicum (Ceylon cinnamon) capsules. Blood samples were measured before and up to 180 minutes post-test. Ingestion of 6 g C. zeylanicum had no significant effect on glucose level, insulin response, glycaemic index, or insulinaemic index.
- Study type
- Randomized crossover trial
- Who was studied
- 10 subjects with impaired glucose tolerance (IGT)
- What was measured
- Postprandial plasma glucose, insulin, glycaemic index, and insulinaemic index
THE PAPER
Ceylon cinnamon does not affect postprandial plasma glucose or insulin in subjects with impaired glucose tolerance.
Wickenberg J, Lindstedt S, Berntorp K, Nilsson J, Hlebowicz J. Br J Nutr, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.